Two years after buying CinCor Pharma for $1.3 billion, AstraZeneca has reported that the main asset in the deal, for uncontrolled or treatment-resistant hypertension, has cleared a phase 3 trial ...

President Trump on Thursday cemented and signed an executive order implementing the US's pact with Japan. But despite this, many of Trump's tariffs remain tied up in legal battles, after courts ruled ...